Cancer has a differentiated nature, in association to organ specificity. All types of cancer have distinctive characters; the basic processes that cause cancer are similar in all forms of cancers. Based on the cancer location in the body organ, it is named as Organ Specific Cancers. The various types of cancers include Breast Cancer, Bone Cancers, Ovarian Cancer, Prostrate Cancer, Neck Cancer, Lung cancer, Head cancer, skin cancer, Bile duct cancer, anal cancer etc. The tumor burden progressively hinders with regular biochemical functions carried out by the host organs. Based on the differences in the cancer cells while they grow, lead to the development of the drug that targets the specific area, which is called Targeted Cancer Therapy. Targeted therapy will not act like Chemotherapy (affecting the parts that are not targeted). The stem cell therapy also provides various way for treating cancer. Cancer Therapy Conferences express various developing therapies for varied cancers.
Pancreatic malignancy rises when cells in the pancreas start to multiply rather to the typical normal and shape a mass. These tumor cells can attack different parts of the body. Pancreatic adenocarcinoma, is the most widely recognized and represents around 85% of cases Pancreatic tumor treatment may consolidate medical procedure alone, a blend of medical procedure and proton treatment, or proton treatment alone, and also chemotherapy. Despite when it is possible to absolutely remove the adenocarcinoma with medical procedure, the likelihood of productive pancreatic development treatment is low; proton treatment for pancreatic tumor might be used after medical procedure to improve contamination control, before medical procedure to specialist the pancreatic tumor, inciting all the more convincing medical procedure, or in lieu of medical procedure. When in doubt, chemotherapy is moreover considered Pancreas is an organ, which assumes a noteworthy job in absorption and hormone production.The diary stocks up data about Pancreatic disorders,Pancreatitis, Pancreatic tumor, Gall bladder side effects, Gallbladder illness, Pancreatitis indications, Acute pancreatitis, Pancreas torment, Chronic pancreatitis, Biliary dyskinesia, Inflamed pancreas, Gallstone pancreatitis, Pancreatic pipe, Acute pancreatitis side effects, Pancreas life structures, Swollen pancreas, Pancreatic compound substitution treatment, Hereditary pancreatitis, Proton treatment pancreatic malignancy, Pancreatectomy, strategies for location, distinctive treatments and propelled medications to conquer pancreatic scatters. Pancreatic Disorders and Therapy is a companion surveyed medicinal diary that incorporates an extensive variety of subjects in this field and makes a stage for the creators to contribute towards the diary
Biopsy is a medical examination usually done by a surgeon, an interventional radiologist, or an interventional cardiologist concerning extraction of sample cells or tissues for scrutiny to determine the existence of a disease state. It is of two categories, the Excisional biopsy in which the affected tissues or cells are removed entirely and the Incisional biopsy in which some sample is extracted from the affected region for diagnosis. When cancer is suspected, the first attempt will be Excisional biopsy. In case it doesn’t work they go for incisional biopsy
to determine whether the cancer is benign or malignant. If the area of suspicion is not found, X- rays or ultrasound can be used to trace the area, known as Ultra sound guided biopsy or Stereotactic guided biopsy. The safest mode of diagnosis and a minor surgical procedure is called Fine needle aspiration. A non-invasive method of diagnosing cancer is Liquid biopsy. Cancer pathogenesis is another important procedure after biopsy. Cancer Science and Therapy Conferences paves way towards a break-through in the field of cancer research.
The elective solution for growth is something which is given for the tumor patients as a substitute to the current treatments, which are not demonstrated by the Nourishment and Medication Organization - FDA. The Back rub treatment have demonstrated some great outcomes yet they are just brief. Different treatments like strong psychotherapy and entrancing shows extremely feeble outcomes. The Subjective treatment indicated direct advantages however again it is likewise brief. The recommendation for Music treatment is questionable, and certain natural obstructions are extremely harmful to some tumor patients. The Needle therapy Treatment is likewise being dominatingly utilized elective medications, yet with extremely frail outcomes. Every one of these medications will give just misleading impacts, simply that for growth treatment. Tumor Science Gatherings serves to investigations the simultaneous courses in growth treatment
Certain sorts of chemotherapy and radiation treatment can cripple the safe structure, putting harm patients at extended risk everlastingly undermining illnesses. Thusly, various tumor patients may need to get revaccinated against diseases they got vaccinations for as adolescents. Antibodies require a sound immune structure that is prepared to see and execute sickness causing germs. Besides, it takes a sound invulnerable system no under 2 weeks from the period of inoculation to start seeing and disposing of germs. That infers vaccination timing is also as basic as getting the inoculation itself. At the point when all is said in done, inoculations isn't recommended in the midst of chemotherapy or radiation treatment
are substances that act as indicators of the cancer site in the body. Usually biomarkers are computable indicators of the biological state in the body, a molecule that is unleashed by the tumor or in response to the presence of tumor. Biomarkers are used for the assessment of risk in cancer patients. They are specifically related with genetic mutations or epigenetic alterations that show a measurable way to find the tumor cells. The advantages of biomarkers are that they can be used as a diagnostic tool, and can also determine whether the tumor is localized or metastatic in nature. Cancer prognosis can be determined by biomarkers
. Cancer recurrence is also being examined by the biomarkers.
Cancer case report give thorough details about the diagnosis, treatments,follow ups, and the demographic profile of the patient. The literature review of other patients may also be present in a report for reference. In cancer metastasis, the case report plays an important role for treating the patient. It makes for a good cancer therapy database which could be useful for education and research. The cancer pathogenesis and its effects can be depicted in a case report. The case report is considered to be an anecdotal evidence, something which is considered very personal. Statistical sampling of the cancer patients may also be present in a case report for future reference. Cancer Therapy Conferences is a platform to innovate novel therapy for cancer.
The people who take special care of cancer patients are Oncology nurses, this can be termed as oncology nursing. The oncology nurses give counselling
to cancer patients. Cancer nursing coaching is given to improve the expansion of the nursing vocation. This is an exclusive course of medical edification which gives theoretical and practical training to mould them as nursing care experts. The global expansion requires the acceptance of knowledgeable status by involving together. This indicates that the appreciations of claim for a more clearly articulated nursing role are combined during work involvement. This confirms about the perseverance and value of role recurrence and relations with an official group as part of the enlightening procedure. Nursing Management
is an important chapter in nursing education. The nursing professionals in radiation oncology field are in high demand. Oncology nursing professionals mostly give palliative care for patients and comfort them. Cancer science meetings will help create a revolution in cancer science and cancer nursing field.
Targeted Cancer Therapy is one of the finest therapies in treating cancer. The cancer cells are treated by targeting and inhibiting specific molecules that are responsible for tumor progression. This blocking can be done by molecular medicine. It is better than the usual chemotherapy, which only hinders the uncontrollable tumor growth. Molecular medicine is an extensive field that uses various tools to define the molecular structure and its mechanism, recognize errors in genes and to develop molecular interferences to treat them. Since most of the molecules used for targeting are biopharmaceuticals, this can also be referred as Biotherapy. Apart from Biotherapy, the Targeted Cancer therapy can use Nano-engineered enzymes. These enzymes bind to the cancer cell so that the natural cell degradation system of the body kills,digests and eliminates it from the body. Organ-Defined Cancers can be effectively treated by the Targeted therapy. Cancer Therapy Conferences
reveals broad range of knowledge about targeted therapies for treating cancer.
The spread of cancer from one part of the body to another part or to lymph nodes, which are not directly connected to each other, is called Cancer Metastasis. Cancer is considered as a deadly disease mainly because of its ability to spread in the body. Metastasis takes place through the blood stream or the lymph system. The most common metastasis parts of the body are the lungs, bones, liver and the brain. The metastatic cancer cells do not resemble the feature of cells where it is actually found but resembles the primary cancer cells i.e. it is considered as the next stage of primary cancer cells. All metastatic cancers are considered as advanced cancers. The cancer survival and treatment is influenced by whether the cancer cells are localized or spread to other parts. When the cancer starts to spread, it is very difficult to control. Even if the treatment is continued, it will be only palliative care. The pain control will be mostly by Anti-cancer drugs i.e. chemotherapy. Cancer Management is a multidisciplinary approach that deals with various types of cancer complications and its preventive measures. Cancer Conferences is an important key for both educational and clinical guidance for managing cancer patients.
Tumor is a gathering of illnesses driven by naturally nanostructural issues (e.g. DNA issues). In that capacity, there are evident advantages to medications utilizing nanoscale structures and procedures. Moreover, as nanotechnologies are creating at a quick rate, it is likely that numerous new topics will create inside the territory in the following couple of years. On account of this, Malignancy Nanotechnology means to give a gathering with the goal that the most encouraging rising topics ought to be pre-famous in the psyches of specialists working in one or, in reality, both of the controls of growth research or nanotechnology.
Nanomedicine ranges from the therapeutic uses of nanomaterials and organic gadgets, to nanoelectronic biosensors, and even conceivable future utilizations of sub-atomic nanotechnology, for example, natural machines. Current issues for nanomedicine include understanding the issues identified with poisonous quality and ecological effect of nanoscale (materials whose structure is on the size of nanometers, i.e. billionths
Gynecologic oncology is a specialized field of medicine that focuses on cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. As specialists, they have extensive training in the diagnosis and treatment of these cancers. Gynecologic Oncology is a field of medication that spotlights on malignancies of the female conceptive system, including ovarian ailment, uterine development, vaginal tumor, cervical malady, and Vulvar danger. In Cancer science - 2019 speakers will discuss the key concentrations regarding immunotherapy, Insusceptible checkpoint inhibitors to treat ailment, and related examinations of tumor inoculation.As experts, they have wide planning in the assurance and treatment of these tumors.
Transgender Man is the quantifiably higher threat of cervical, ovarian, and uterine development looked by transgender men who hold genitalia they were considered with. In view of disgrace and social dismissal, various don't reliably get gynecological examinations and relating cervical and ovarian screenings. Transgender men are in peril for cervical ailment. Transgender individuals are particularly defenseless against a nonattendance of adequate social protection, particularly concerning sexual and regenerative prosperity. In most of the country's cervical development is a principle wellspring of threat death, transgender men are at high peril of working up this disease. Despite the fact that the Papanicolaou test is the most for the most part used screening system for cervical development, there are high amounts of inadmissible results among transgender men differentiated and nontransgender individuals. Human papillomavirus (HPV) testing may be a more functional screening decision in this masses.
shows the relationship between the immune system and the progression of cancer. The cancer immunotherapy uses the immune system for the treatment of cancer. Cancer cells have some surface molecules on them that prevent the immune system from recognizing them as cancer cells. In immunotherapy those surface molecules are targeted and destroyed, so that immune cells can now identify the cancer cells. It is effective, specific, and long term than Chemotherapy and Surgery. Immunotherapy is something that stimulates the cells of immune system to attack the cells of tumor, and hence it can also be called as Biotherapy. To prevent the progression of neoplastic tissue, the immune system identifies the transformed cells which are called cancer immuno surveillance
. Cancer Biomarkers are the best tool for recognizing the location of cancer, which is important for cancer treatment. Cancer Science and Therapy Conferences express great knowledge of therapies and treatments in the cancer field.
The usage of ionization radiation in cancer treatment is known as Radiation Oncology. Chemotherapy and radiation therapy are used as a combination to treat tumor. It also helps reduce the tumor burden. Radiation therapy has some side effects, categorized into immediate and late side effects. The immediate side effects are vomitting, intestinal discomfort, swelling, infertility etc., The late side effects include fibrosis, epilation, heart diseases etc., Sometimes radiation enteropathy
is also experienced by patients. Hormonal imbalances may also occur due to this therapy. Cancer metabolomics is an important tool for cancer detection and treatment. Cancer case reports show evidence for the effectiveness and side effects of radiation therapy
. Cancer Science Conference discloses the recent innovations in cancer therapy field.
Integrative treatment is a dynamic type of psychotherapy that joins diverse remedial apparatuses and ways to deal with fit the necessities of the individual customer. With a comprehension of typical human improvement, an integrative advisor changes standard medicines to fill being developed holes that influence every customer in various ways. By joining components drawn from various schools of mental hypothesis and research, integrative treatment turns into a more adaptable and comprehensive way to deal with treatment than more conventional, solitary types of psychotherapy .Integrative therapy is more inclusive of the client than traditional forms of therapy, where the client plays a less active role in treatment. Integrative psychotherapists consider the individual characteristics, preferences, needs, physical abilities, spiritual beliefs, and motivation level of their clients and use their professional judgment to decide the best approach to therapy for each client. Different approaches may be used consecutively throughout different stages of the therapeutic process or they may be used as a single combined form of therapy throughout.
There are significant challenges to global drug development in the recent years. Despite vast research and development in the field of oncology, the translation of research advance into medicines that substantially improve the treatment of many cancers is witnessing slow growth. What could be the key challenges in anticancer drug development, and how can they be addressed? Some of the major threats the pharmaceutical industry is now facing, include the increase in the cost of research and development without an attenuated improvement in productivity (i.e, the number of agents approved), the longer duration of development without a corresponding decrease in development risk; and the increasingly conservative regulatory climate coupled with the increasingly difficult reimbursement setting. Cancer Science-2019 provides a global platform to share developments concerned to Anti-cancer drugs.
Artificial Intelligence in the treatment of cancer could be a break-through globally in the field of cancer. When cancer is detected at an early stage, treatment is more likely to be successful. But too often, cancers are diagnosed at a later stage when they are much harder to treat. There are many reasons for this, including that the symptoms people experience could be vague and linked to much less serious conditions. Detecting cancer earlier by interrogating medical and non-medical data sets using machine and deep-learning is a possible solution to prevent cancer or at the least, identify cancer at an early stage.
In cancer treatment the already existing treatments usually have many side effects and are highly poisonous, which could reduce the quality of life. This incorporates the discovery of novel approaches in cancer treatment. The most important approach is the cancer immunotherapy, in which the activation of immune system is done for the treatment of cancer. Traditionally the Cytokine therapy is considered as a backbone of immunotherapy
. Peptide vaccines, tumor cell vaccines, immune cell vaccines, cancer vaccines are considered as a novelist finding in cancer field. In hematologic malignancy. the Adoptive Cell therapy is deliberated as a new practice for cancer therapy. The Molecular Cancer therapy is reflected as a novel approach in cancer treatment. Tumor Immunology plays an important role in verdict of new approaches for cancer therapeutics. Cancer Conferences expresses
its effort to combat cancer.
Pharmacology deals with the study of action of drug in the body. Though some drugs showed good results in animal model, were not effective when used in cancer patient of less tumor burden. In such cases the tumor burden is first reduced by cancer surgery and then followed by chemotherapy. This is called as adjuvant therapy. In combination with chemotherapy, a heat therapy called Hyperthermia therapy can be used to control various cancer types. Electric voltage passed through tumor cells to stop their progression along with chemotherapy process is known as Electro chemotherapy
. The use of chemotherapy alone for cancer treatments leads to many side effects like cardiotoxicity, nephrotoxicity, ototoxicity etc., Cancer genetics is helpful for identifying the mode of treatment for Cancer. Cancer biomarkers
effectively assist in finding tumor cells and treating them. Cancer Conferences gives a perception about the new strategies emerging in cancer therapy.
Cancer is a genetic disease triggered by an increase in DNA mutations
and epigenetic alterations that leads to uncontrolled cell proliferation and neoplasm formation. Mutation occurs frequently in the body of human, but still can be controlled. So, it won’t be possible to cause cancer with one mutation. Generally, it takes numerous mutations in the lifetime of a human to cause cancer. This is the reason older people have cancer, as they have had multiple chances for mutations. Oncogenomics deals with the characterization of cancer- associated genes. Tumor suppressor genes or oncogenes are the ones that manage the cell cycle process, hence they are called the Protective cells. These genetic
changes escalate the risk of cancer. The presence of mutated genes in germ cells can be inherited to the off springs. Cancer Pharmacology
deals with studying the action of drugs on cancer patients. Cancer science meetings explore new ideas and techniques for cancer therapy.
As the name depicts, stem cells are used in this therapy for the treatment of some types cancer. An undifferentiated cell, that can be differentiated into a specific cell or multiple copies of the own cell is called stem cell
. These stem cells are predominant in multicellular organisms. There are two kinds of stem cells, the Embryonic stem cells (derived from the blastocyst inner cell mass) and the Adult stem cells (derived from tissues of an adult). The Adult cells combined with the progenitor cells acts as a repair system of the body. During cancer therapies like chemotherapy
, the stem cells could get destroyed due to high radiations. Stem cell transplants are generally used to treat or maintain stem cell level in cancer patients. There are many Cancer Case Reports showing this therapy as an effective treatment for cancer. Cancer Conferences act as a podium for gaining knowledge about the new inventions in cancer stem cell therapy
EuroScicon invites participants from across the globe to join the “International Conference on Cancer Science” going to be held during February 19-20, 2019, Prague, Czech Republic. The conference includes Keynote Presentations, Oral Talks, Poster Presentations, Product Launches and Exhibitions. Cancer Science-2019 is a specially designed cluster conference, whose main theme is “Recent Development and Advancements of Cancer Science ”. This event covers a wide spectrum of critically important sessions.
For more details please visit: https://cancerscience.euroscicon.com/
Importance & Scope:
Cancer is the second highest leading cause of death in the world. It’s essential that we remember cancer is not one disease – it’s more than 200 cancer diseases involved, each of them different requiring respectively suitable approaches for their cure. Treatments that work for some cancers do not work for others, and there are some cases where treatments simply stop working abruptly, reasons being unknown. To overcome these problems, only a global search for answers is what is to be called for.
The conference will provide exceptional opportunities for Delegates from Universities and Institutes to interact with world-class Scientists and Industrial Professionals working in the field of cancer/oncology. Cancer Science 2019 will explore new ideas and advancements on a global scale in topics like Cancer Science & Therapy, Cancer Cell Biology, Organ-Defined Cancers, Tumour Science, Cancer Genetics, Clinical Cancer Research, Cancer & Tumour Immunology, Cancer : Genomics & Metabolomics, Targeted Cancer Therapy, Stem Cell Therapy, Cancer Biomarkers, Cancer Treatment & Therapeutics, Cancer Clinical Trials, Cancer Case Reports, Cancer Drug Diagnostics & Therapeutics, Frontiers in Cancer Science, Precision Medicine & Cancer Therapy, Cancer Management & Prevention, Economic Impact of Cancer Therapy.
The Amsterdam Metropolitan Area is home to some of the world’s largest museums, iconic locations and the famous 400-year-old Canal Ring. Amsterdam is a top international destination for conventions and conferences, and hosts an average of 650 meetings per year, attracting over 700,000 business visitors. Visitors of all types have plenty to do while they’re here. The city’s cultural agenda is packed with world-class exhibitions, theatre performances, live music and other spectacular events, and its charming neighborhoods are full of shops, cafes and restaurants. The resources below will give an overview and helps you plan the right itinerary.
In the recent days, the Netherlands Cancer Institute - Anton van Leuwenhoek Hospital accommodates approximately 550 Scientists and Scientific Support Personnel, 53 Medical Specialists, 180 beds, an out-patients clinic with 30,600 visits, six operating theaters, and eleven Irradiation units. It is the only dedicated cancer center in the Netherlands, officially accredited as Comprehensive Cancer Center by the OECI, and holds importance as the National and International center for scientific and clinical expertise, development and training. The Cancer Center, Amsterdam houses one of the largest oncology research centers in the Netherlands, joining cancer researchers from the Academic Medical Center and the VU University Medical Center, Amsterdam. All researchers, clinicians, technicians, research nurses and other people involved in oncological research are invited to attend the conference, From the day the NKI-AVL was established, close collaboration between scientists and clinicians was seen as an essential element in fighting cancer. Having a laboratory and hospital under one roof in a single independent organization with an open and collaborative atmosphere has led to many important discoveries and improved therapies.
Market Analysis Report:
In the recent years there have been advancements & innumerable therapies and the search for cancer treatments has been accelerating. The recent reports on the global cancer diagnostics market for the forecast period of 2015 to 2020 speculates that this market is expected to reach $13.1 Billion by 2020 from $7.1 Billion in 2015, and is poised to grow at a Compound Annual Growth Rate (CAGR) of 12.9% during the forecast period. The global cancer diagnostics market is beholding a rapid transformation owing to several technological advancements in the diagnostic field.
BCC Research reports show the global market for next generation cancer diagnostic as $1.6 billion in 2013 which has reached $1.8 billion in 2014 and is expected to reach $10 billion in 2019, registering a compound annual growth (CAGR) of 42.6% over the five-year period.
The global cancer diagnostics market is segmented based on technology, application, and region.
Based on technology, the cancer diagnostics market is categorized into Platform-based and Instrument-based. The Instrument-based segment was expected to account for a major share of the cancer diagnostics market, in 2015. Based on the application, the cancer diagnostics market is segmented into Lung cancer, Breast cancer, Colorectal cancer, Melanoma, and others. Breast cancer application was expected to consider for a major share of the cancer diagnostics market, by application in 2015. Based on region, the market is divided into North America, Europe, Asia, and Rest of the World. Rest of the World part comprises Latin America, Pacific countries, and Middle East and Africa. North America is seen to reckon for the largest share in the cancer diagnostics market, followed by Europe and Asia. However, the Asian market is slated to grow at the highest CAGR in the coming five years and serves as a revenue pocket for the companies operating in the cancer diagnostics market.
Figure 1: Cancer Diagnostic Market by Region (2015- 2020)
The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach $4.3 billion in 2019, registering a compound annual growth rate (CAGR) of 1.3% for the period 2014-2019, while the global cancer vaccines market is expected to grow at a CAGR of 12-18% over the period (2017 - 2022). Global revenue for vaccine was nearly $31.8 billion in 2011. This market has increased from $33.6 billion in 2012 and is expected to increase to $43.4 billion in 2018 at a compound annual growth rate of 5.3%.
Figure 2: Cancer Vaccine Market Revenue (2014- 2019)
The global ovarian cancer drug and diagnostic market was valued at $16.1 billion in 2012 and $18.7 billion in 2013 and is expected to reach $34.6 billion by 2018, a compound annual growth rate of 13.1% between 2013 and 2018.
The global market for cancer profiling reached $26.1 billion in 2012 and nearly $30.1 billion in 2013 and is expected to reach $54.8 billion in 2018, a compound annual growth rate of 12.8% over the five-year period, 2013 to 2019.
Past Conference Report
We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Cancer Science – 2018 Conference the successful!
1st Edition of World congress on Cancer Science – 2018, hosted by the Euroscicon Ltd. was held during July 23-24, 2018 at HYATT PLACE, Amsterdam, Netherlands based on the theme “The Current Advancements in Cancer science-2018 " which got magnificent response. With the support and guidance of Organizing Committee Members and Editorial Board Members and astonish presentations of all participants along with Scientists, Researchers, Students and leaders from various fields of Oncology made this event a grand success.
Euroscicon Ltd expresses its gratitude to the conference Moderator, namely Dr. Mohamed Mostafa Rizk, University of Alexandria, Egypt for taking up the responsibility to coordinate during the sessions for smooth functioning of this event. We are indebted to your support. A very special thanks to our Exhibitors and Sponsors to have bestowed and their faith and invested in us to make this event a fruitful one. We hope you continue your support in our future endeavours. The conference was initiated with the Honourable presence of the Keynote forum. The speakers list includes:
Dr. Weisi Yan, University of South Alabama, USA
Dr. Donglu Shi, University of Cincinnati, USA
Dr. Igor Smit, Ijsselland Ziekenhuis, Netherlands
Dr. Kenji Ohe, Fukuoka University, Japan
Dr. Dwayne N. Jackson, University of Western Ontario, Canada
Dr. Mohamed Mostafa Rizk, University of Alexandria, Egypt
Dr. Jiangwen Zhang, University of Hong Kong, Hong Kong
Dr. María del Rosario Davalos Gamboa, University of San Simon, Bolivia
Dr. Jose Antonio Matute Briceno, Sonora Cancer Research Center-Cics USA, Mexico
Dr. Wassil Nowicky, Ukrainian Anti-Cancer Institute, Austria
Dr. Mohammed Y Almaghrabi, Jing Abdullah Medical City, Kingdom of Saudi Arabia
Dr. Jan Jacques Michiels, Goodheart Institute and Foundation in Nature Medicine & Health, Netherlands
Dr. Kamlesh Guleria, Guru Nanak Dev University, India
Dr. Adnan Yousif Rojeab, London College UCK, U.K
Dr. Marjan Jalalimehr, Razi institute, Iran
Dr. George Kunudji, Bikbok Herbal Centre, Ghana
Dr. Jana Slobodníkova, Alexander Dubcek University of Trencin, Slovakia
Dr. Dina Ron, Israel Institute of Technology, Israel
The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:
Types Of Cancer
Cancer Research & Cancer Vaccines
Antibody Therapy Of Cancer
Combining Cancer Immunotherapies
Immune Checkpoint Inhibitors
Radiology And Imaging In Cancer
Cancer Prognosis & Diagnosis
Cancer Micro And Immuno Environment
Stem Cell Therapy
Biomarker And Drug Targeting
Cancer Genomics And Metabolomics
Cancer & HIV
Tumor Immuno Therapy Research
Euroscicon Ltd also took the privilege of felicitating and Cancer Science – 2018 Organizing Committee, Editorial Board Members of Archives in Cancer Research, Keynote Speakers, Chair and Co-Chairs, Moderator and Exhibitor who supported this event. With the grand success of Cancer Science – 2018, Euroscicon Ltd is proud to announce the “International conference on Cancer Science – 2019" to be held soon.
For More details visit: https://cancerscience.euroscicon.com/2018